Related Experiment Video
Updated: Apr 12, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
[Copy number variation: markers and predictors for type 2 diabetes]
Alan Gilberto Ramírez-Valverde1, Diana Lizzete Antúnez-Ortiz, Alberto Méndez-Beleche
1Unidad de Investigación Médica en Bioquímica, Hospital de Especialidades "Bernardo Sepúlveda", Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Distrito Federal, México. mcruzl@yahoo.com.
DNA copy number variations (CNVs) are linked to type 2 diabetes (T2D). Understanding these genetic variations is crucial for identifying T2D risk biomarkers and improving patient outcomes.
Area of Science:
- Genetics and Genomics
- Metabolic Diseases
- Molecular Biology
Background:
- Type 2 diabetes (T2D) is a global health concern, influenced by environmental, lifestyle, and genetic factors.
- T2D impairs insulin production or action, significantly impacting psychological well-being and quality of life.
- Recent research suggests an association between DNA copy number variations (CNVs) and diseases like obesity and T2D.
Purpose of the Study:
- To investigate the role of DNA copy number variations (CNVs) in the pathogenesis of type 2 diabetes (T2D).
- To characterize the contribution of CNVs to metabolic disease development.
- To explore the potential of CNVs as biomarkers for genetic risk in T2D.
Main Methods:
- Analysis of DNA copy number variations (CNVs) across the genome.
- Assessment of the impact of CNVs on gene expression (mRNA and protein levels).
- Correlation studies to link CNV presence with T2D and related metabolic conditions.
Main Results:
- CNVs are present in 9-18% of the human genome.
- CNVs can alter the expression of nearby genes.
- Further research is needed to fully elucidate the specific contribution of CNVs to T2D pathogenesis.
Conclusions:
- DNA copy number variations (CNVs) represent a significant area for understanding the genetic underpinnings of type 2 diabetes (T2D).
- Characterizing CNVs' role in metabolic diseases is essential for developing novel diagnostic and prognostic tools.
- CNVs hold potential as biomarkers for identifying individuals at genetic risk for T2D.
More Related Videos
10:34Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death
Published on: December 21, 2016
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Single Nucleotide Polymorphisms-SNPs